The pace at which new biological data is being generated is creating a deluge and the use of bioinformatics methods is the only way to cope with this flood of information.
January 4, 2006 (Press Release) --
The pace at which new biological data is being generated is creating a deluge and the use of bioinformatics methods is the only way to cope with this flood of information. Our strength in R&D technology will convert the raw data into information that can be used to discover and develop new drugs.
Some of the future R&D markets earmarked by Indian service providers include, High Performance Computing, Wireless and Mobile applications, Nanotechnology and Digital Signal Processing. There will be a spurt in R&D outsourcing which will fetch revenues of around $1.5 billion by 2004-05.
According to the market research report "World Bioinformatics Market [2005-2010]" published by RNCOS, the Indian bioinformatics industry is slated to touch approximately $2.2 billion by 2006, and about $3.1 billion by 2010.
The report further divulges that an ITES firm has invested Rs.78.6 million in the Biosuite software, whose total cost is Rs.148.6 million. It is capable not only of analyzing raw genetic and protein data, but also the toxicity of potential drug molecules. The ITES firm promises to accelerate progress in drug discovery and to realize the promise of post-genomics biology.
The development of the BioSuite software is a major opening for India in the global bioinformatics field. A number of leading academic and technological institutions have extended their support and infrastructure for the development of this revolutionary project.
To purchase your copy: http://www.marketsmonitor.com/category/Biotech13.html
For more information about the report please visit www.marketsmonitor.com
Some of the future R&D markets earmarked by Indian service providers include, High Performance Computing, Wireless and Mobile applications, Nanotechnology and Digital Signal Processing. There will be a spurt in R&D outsourcing which will fetch revenues of around $1.5 billion by 2004-05.
According to the market research report "World Bioinformatics Market [2005-2010]" published by RNCOS, the Indian bioinformatics industry is slated to touch approximately $2.2 billion by 2006, and about $3.1 billion by 2010.
The report further divulges that an ITES firm has invested Rs.78.6 million in the Biosuite software, whose total cost is Rs.148.6 million. It is capable not only of analyzing raw genetic and protein data, but also the toxicity of potential drug molecules. The ITES firm promises to accelerate progress in drug discovery and to realize the promise of post-genomics biology.
The development of the BioSuite software is a major opening for India in the global bioinformatics field. A number of leading academic and technological institutions have extended their support and infrastructure for the development of this revolutionary project.
To purchase your copy: http://www.marketsmonitor.com/category/Biotech13.html
For more information about the report please visit www.marketsmonitor.com
Email
Print
SPAM
